Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS.
Saved in:
| Title: | Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS. |
|---|---|
| Authors: | Rademaker E; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl., Filippini DFL; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Haitsma Mulier JLG; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands., Slim MA; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Amstel RBE; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bhavani SV; Department of Medicine, Emory University, Atlanta, Georgia., Juffermans NP; Laboratory of Translational Intensive Care, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands., de Grooth HS; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Derde LPG; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands., Cremer OL; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Bos LDJ; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands. |
| Corporate Authors: | Amsterdam U. M. C. COVID-19 Biobank Study Group |
| Source: | Intensive care medicine experimental [Intensive Care Med Exp] 2025 Jul 09; Vol. 13 (1), pp. 70. Date of Electronic Publication: 2025 Jul 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag, GmbH Country of Publication: Germany NLM ID: 101645149 Publication Model: Electronic Cited Medium: Print ISSN: 2197-425X (Print) Linking ISSN: 2197425X NLM ISO Abbreviation: Intensive Care Med Exp Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40632330 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rademaker+E%22">Rademaker E</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl.<br /><searchLink fieldCode="AU" term="%22Filippini+DFL%22">Filippini DFL</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Haitsma+Mulier+JLG%22">Haitsma Mulier JLG</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Slim+MA%22">Slim MA</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Amstel+RBE%22">van Amstel RBE</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bhavani+SV%22">Bhavani SV</searchLink>; Department of Medicine, Emory University, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Juffermans+NP%22">Juffermans NP</searchLink>; Laboratory of Translational Intensive Care, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Grooth+HS%22">de Grooth HS</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Derde+LPG%22">Derde LPG</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cremer+OL%22">Cremer OL</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bos+LDJ%22">Bos LDJ</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Amsterdam+U%2E+M%2E+C%2E+COVID-19+Biobank+Study+Group%22">Amsterdam U. M. C. COVID-19 Biobank Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101645149%22">Intensive care medicine experimental</searchLink> [Intensive Care Med Exp] 2025 Jul 09; Vol. 13 (1), pp. 70. <i>Date of Electronic Publication: </i>2025 Jul 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%2C+GmbH%22">Springer-Verlag, GmbH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101645149 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2197-425X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222197425X%22">2197425X </searchLink><i>NLM ISO Abbreviation: </i>Intensive Care Med Exp <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40632330 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40635-025-00779-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 70 Titles: – TitleFull: Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rademaker E – PersonEntity: Name: NameFull: Filippini DFL – PersonEntity: Name: NameFull: Haitsma Mulier JLG – PersonEntity: Name: NameFull: Slim MA – PersonEntity: Name: NameFull: van Amstel RBE – PersonEntity: Name: NameFull: Bhavani SV – PersonEntity: Name: NameFull: Juffermans NP – PersonEntity: Name: NameFull: de Grooth HS – PersonEntity: Name: NameFull: Derde LPG – PersonEntity: Name: NameFull: Cremer OL – PersonEntity: Name: NameFull: Bos LDJ IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 07 Text: 2025 Jul 09 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2197-425X Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Intensive care medicine experimental Type: main |
| ResultId | 1 |